Martin Smoragiewicz

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Induced Pluripotent Stem Cells

Immune Response

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Clinical cancer research : an official journal of the American Association for Cancer Research

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Martin Smoragiewicz, Alex A Adjei, Emiliano Calvo, Josep Tabernero, Aurélien Marabelle, Christophe Massard, Jun Tang, Elisabeth G E de Vries, Jean Yves Douillard, Lesley Seymour, null null
Design and Conduct of Early Clinical Studies of Immunotherapy: Recommendations from the Task Force on Methodology for the Development of Innovative Cancer Therapies 2019 (MDICT). Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Daniele Biasci, Martin Smoragiewicz, Claire M Connell, Zhikai Wang, Ya Gao, James E D Thaventhiran, Bristi Basu, Lukasz Magiera, T Isaac Johnson, Lisa Bax, Aarthi Gopinathan, Christopher Isherwood, Ferdia A Gallagher, Maria Pawula, Irena Hudecova, Davina Gale, Nitzan Rosenfeld, Petros Barmpounakis, Elizabeta Cristina Popa, Rebecca Brais, Edmund Godfrey, Fraz Mir, Frances M Richards, Douglas T Fearon, Tobias Janowitz, Duncan I Jodrell
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proceedings of the National Academy of Sciences of the United States of America 117 (46) (2020)
Sarah Lapointe, Warren Mason, Mary MacNeil, Craig Harlos, Roger Tsang, Joana Sederias, H Artee Luchman, Samuel Weiss, John P Rossiter, Dongsheng Tu, Lesley Seymour, Martin Smoragiewicz
A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study. Investigational new drugs 38 (4) (2019)